Read all posts

Common Cholesterol Drugs May Not Lower Risk Of Parkinson’s Disease; Evidence Behind Statins’ Benefits Is Shaky

If cholesterol-lowering statins were able to prevent Parkinson's disease, we'd have a powerful new way to prevent or delay the neurodegenerative disease. However, the research on its effectiveness in doing that is shaky; a new study shakes things up even more, finding that statins may not only be unable to lower Parkinson's risk but possibly even worsen it.

Read the article on Medical Daily

Dr. Sears Comments:

Dr. Barry Sears

The article failed to mentioned that stains are also the only known drug that increases arachidonic acid formation.  In the brain that means more neuroinflammation, and that’s bad for a Parkinson’s patient.

Leave a Reply

Your email address will not be published. Required fields are marked *